Âé¶¹´«Ã½360 Healthcare Authority: Healthcare Authority Deals & Corporate Governance /healthcare-authority/deals-corporate-governance?utm_source=rss&utm_medium=rss&utm_campaign=section Latest articles for: Healthcare Authority Deals & Corporate Governance Copyright 2025 Âé¶¹´«Ã½. en-US Fri, 06 Jun 2025 23:04:02 +0000 Masimo Fights Ex-CEO's Bid To Ax Suit Over $450M Demand /healthcare-authority/deals-corporate-governance/articles/2350526?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2350526 Masimo Corp. fought back against founder Joe Kiani's motion to dismiss the company's Delaware Chancery Court suit seeking a declaration that he's not due a $450 million payout after his ouster as CEO, arguing that bid is an "improper attempt to evade" the Delaware court's jurisdiction. Fri, 06 Jun 2025 14:21:42 +0000 Taxation With Representation: Winston, Stibbe, Weil, Goodwin /healthcare-authority/deals-corporate-governance/articles/2350469?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2350469 In this week's Taxation With Representation, Chart Industries Inc. and Flowserve Corp. merge, Aedifica NV and Cofinimmo NV unite, Sanofi buys Blueprint Medicines Corp., and Kimberly-Clark Corp. sells a majority stake in its international tissue business to Suzano. Thu, 05 Jun 2025 21:54:58 +0000 Latham-Led Virtual Health Startup Omada Prices $150M IPO /healthcare-authority/deals-corporate-governance/articles/2349007?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2349007 Venture-backed virtual care provider Omada Health Inc. on Thursday priced a $150 million initial public offering within its marketed range, represented by Latham & Watkins LLP and underwriters counsel Davis Polk & Wardwell LLP. Thu, 05 Jun 2025 21:10:13 +0000 Elon Musk Seeks $5B For AI Startup, Amid Other Reports /healthcare-authority/deals-corporate-governance/articles/2349461?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2349461 Elon Musk is planning a $5 billion debt sale for his AI startup, Ontario’s pension seeks final bids for an Indian hospital system, and Merck eyes a Swiss biotech with a potential $3 billion price tag. Here's a rundown of these and other notable deal rumors from the last week. Thu, 05 Jun 2025 21:04:51 +0000 $1.36B Home Healthcare Deal Dropped Amid FTC Scrutiny /healthcare-authority/deals-corporate-governance/articles/2349928?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2349928 Healthcare solutions company Owens & Minor said Thursday that it's abandoning its $1.36 billion plan to buy home-based care business Rotech Healthcare Holdings after the Federal Trade Commission's scrutiny proved too much to bear. Wed, 04 Jun 2025 21:39:33 +0000 States Take Aim At Healthcare REITs /healthcare-authority/deals-corporate-governance/articles/2349574?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2349574 State lawmakers seeking to curb healthcare investment models they see as harmful to patients have sharpened their focus on real estate investment trusts, putting forth bills to restrict their ownership of healthcare real estate or increase oversight of such transactions. Tue, 03 Jun 2025 19:21:31 +0000 InnovAge To Pay $27M To Resolve IPO Investors' Suit /healthcare-authority/deals-corporate-governance/articles/2348678?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2348678 InnovAge Holding Corp. and a class of stockholders have agreed to a $27 million settlement to resolve claims that the senior-health care company made misleading statements in an initial public offering that later caused stock prices to tank after a government audit exposed the falsehoods. Tue, 03 Jun 2025 18:50:55 +0000 Latham Advises Atai In $390M Merger With Beckley Psytech /healthcare-authority/deals-corporate-governance/articles/2347876?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2347876 U.S.-German biopharmaceutical company atai Life Sciences, advised by Latham & Watkins LLP, said in an announcement Monday that it will acquire Beckley Psytech, led by Mayer Brown LLP and CMS Cameron McKenna Nabarro Olswang LLP, in an all-share transaction that values Beckley at approximately $390 million, creating a combined company focused on fast-acting mental health therapies. Tue, 03 Jun 2025 17:59:33 +0000 Stibbe, A&O Shearman Guide $13.8B Healthcare REIT Merger /healthcare-authority/deals-corporate-governance/articles/2348801?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2348801 Belgian real estate investment trusts Aedifica NV and Cofinimmo NV said Tuesday they have agreed to merge, forming what they said will be Europe's largest healthcare real estate investment trust, with a combined gross asset value of approximately €12.1 billion ($13.8 billion). Tue, 03 Jun 2025 16:30:24 +0000 Georgia Health System Selects Legal Chief As CEO /healthcare-authority/deals-corporate-governance/articles/2348232?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2348232 The Southeast Georgia Health System Inc. has installed its interim president and chief executive officer — who was most recently its chief legal officer — as president and CEO. Tue, 03 Jun 2025 16:13:44 +0000 Simpson Thacher Adds Ex-Weil M&A Pro In NYC /healthcare-authority/deals-corporate-governance/articles/2348124?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2348124 Simpson Thacher & Bartlett LLP announced Monday the hiring of a former counsel at Weil Gotshal & Manges LLP as a partner in its mergers and acquisitions practice in New York. Tue, 03 Jun 2025 14:00:31 +0000 The Âé¶¹´«Ã½360 400: A Look At The Top 100 Firms /healthcare-authority/deals-corporate-governance/articles/2345428?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2345428 A rebound in client work sent the nation’s largest law firms into growth mode last year, driving a wave of hiring, mergers and strategic moves that reshaped the top tier of the Âé¶¹´«Ã½360 400. Here's a preview of the 100 firms with the largest U.S. attorney headcounts. Tue, 03 Jun 2025 10:00:30 +0000 Katten Adds 4 Ex-Kirkland Attys To Healthcare Practice /healthcare-authority/deals-corporate-governance/articles/2347429?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2347429 Katten Muchin Rosenman LLP announced Tuesday that it has hired two partners and two associates from Kirkland & Ellis LLP to boost Katten's regulatory and transactional expertise in the firm's healthcare practice. Mon, 02 Jun 2025 14:13:38 +0000 Healthcare REIT, JV Pay $146M For Skilled Nursing Portfolio /healthcare-authority/deals-corporate-governance/articles/2347959?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2347959 Healthcare-focused real estate investment trust CareTrust REIT Inc. on Monday announced the acquisition of 10 skilled nursing facilities across the Pacific Northwest for $146 million. Tue, 27 May 2025 22:47:42 +0000 Bluebird Bio Beats Investor Suit Over FDA Cancer Warning /healthcare-authority/deals-corporate-governance/articles/2345379?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2345379 Massachusetts-based biotechnology company Bluebird Bio Inc. has beaten a shareholder suit accusing it of misleading investors about the likelihood of the U.S. Food and Drug Administration's decision requiring a "black box warning" on one of its products due to the cancer risk it posed. Tue, 27 May 2025 20:20:52 +0000 Pharma Co. Says Chubb Failed To Pay Covered Defense Costs /healthcare-authority/deals-corporate-governance/articles/2345414?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2345414 A New Jersey pharmaceutical company said Chubb owes nearly $6.5 million in outstanding defense costs related to a multibillion-dollar arbitration dispute over the manufacture of an antiviral drug, according to a suit removed to federal court Tuesday. Tue, 27 May 2025 18:19:06 +0000 Paris VC Firm Cathay Closes $1B AI Venture Capital Fund /healthcare-authority/deals-corporate-governance/articles/2345334?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2345334 Paris venture capital firm Cathay Innovation said Tuesday that it has closed a $1 billion fund focused on artificial intelligence investments. Tue, 27 May 2025 17:50:50 +0000 US Trustee Wants Steward Health Switched To Ch. 7 /healthcare-authority/deals-corporate-governance/articles/2345276?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2345276 The U.S. Trustee's Office is asking a Texas bankruptcy judge to convert Steward Health Care's Chapter 11 case to a court-supervised Chapter 7 liquidation, saying the hospital chain cannot pay the bills it has run up during its bankruptcy. Tue, 27 May 2025 15:22:22 +0000 Eli Lilly Inks $1B Deal For Non-Opioid Pain-Drug Maker /healthcare-authority/deals-corporate-governance/articles/2345321?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2345321 Eli Lilly announced Tuesday that it has inked a potentially $1 billion deal to buy SiteOne Theraputics, giving the pharmaceutical giant access to a non-opiod pain medicine ready for phase 2 trials.  Fri, 23 May 2025 17:40:23 +0000 FTC Probing Alcon's $430M Lensar Deal /healthcare-authority/deals-corporate-governance/articles/2344372?utm_source=rss&utm_medium=rss&utm_campaign=section /healthcare-authority/deals-corporate-governance/articles/2344372 The Federal Trade Commission has requested additional information about Swiss eye care company Alcon Inc.'s planned purchase of Florida-based medical technology developer Lensar Inc. in a deal worth up to $430 million.